Retro Biosciences will back clinical trials for three drugs—including a potential Alzheimer’s disease treatment set to begin ...
Sam Altman, the CEO of OpenAI, has announced a shift in his previously critical perspective on President Donald Trump.
Sam Altman-backed Retro Biosciences is raising $1 billion to develop drugs that extend human lifespan by 10 years, the FT ...
The pictures disclosed in the new Daily Mail article show a blood-stained floor where Suchir Balaji’s head lay. There are ...
Musk vs Altman Explodes | Vantage with Palki Sharma | N18G Barely 72 hours into Donald Trump's presidency, chaos erupts with ...
OpenAI CEO Sam Altman took the technology world by surprise on Thursday with the release of Operator, his company's first AI ...
Their mutual friction goes back to the foundational ideals of OpenAI. But now both seem to have Trump’s favour: Elon Musk as ...
More orders are expected Tuesday amid fallout from his first moves, including his issuing pardons for more than a thousand ...